Lemtrada (also known as alemtuzumab or campath) is a disease modifying treatment (DMT) for highly active relapsing remitting multiple sclerosis. Lemtrada is given as an intravenous infusion (drip), often in two treatment courses, twelve months apart. Clinical trials have shown that Lemtrada reduces relapses by around 50% compared to a placebo.
Ask the community your questions about Lemtrada or read about other people's Lemtrada MS experiences.
546 conversations about Lemtrada
Although officially CIS since 2014, I was only diagnosed with relapsing MS after having a relapse around […]
Hi, I have RRMS, been diagnosed nearly three years. It’s been a while since I’ve posted. Having […]
Hi, please excuse the lack of picture and pseudonym. I am a film director and I’m shooting […]
Hi guys, I hope you are all well and getting ready for the holidays! As some of […]
Hi everyone! Today I had an appointment with my consultant for diagnostic test results and discussion about […]